Senior Business Development Manager - DACH
About the job
- A BA/BS degree or equivalent professional experience.
- 8–12 years of experience in business development, healthcare sales, partnership development, channel sales, or a related commercial role.
- Fluent or native-level German and professional fluency in English.
- Strong experience working with hospitals, radiology departments, imaging centers, radiologists, or other healthcare providers.
- Demonstrated ability to develop customer relationships and navigate complex B2B or healthcare sales processes.
- Strong verbal and written communication skills for communicating with clinical, technical, and business stakeholders.
- Strong presentation and negotiation skills, including the ability to communicate the value of technical products to different audiences.
- Proven ability to manage multiple customers, partners, and commercial opportunities simultaneously while maintaining attention to detail.
- Ability to work independently and take ownership of the assigned market.
- Willingness to travel regularly within Germany and occasionally across the broader DACH region and Europe.
- Experience with CRM software such as Salesforce and proficiency with Microsoft Office, Google Workspace, Slack, and Notion.
- Develop and execute business development and go-to-market strategies for Germany and the broader DACH market, with Germany as the primary focus.
- Identify and pursue new business opportunities across hospitals, radiology groups, imaging centers, healthcare networks, and other relevant healthcare organizations.
- Build relationships with radiologists, radiology department leaders, hospital management, procurement teams, IT departments, and clinical decision-makers.
- Develop and manage partnerships with distributors, strategic business partners, technology partners, and reference sites.
- Manage the full commercial pipeline from lead generation and qualification through product presentation, evaluation, negotiation, and closing.
- Understand customer needs and clinical workflows and communicate the value of AIRS Medical’s AI solutions within the radiology environment.
- Work with clinical and technical teams on MRI workflows, PACS, DICOM, hospital IT environments, and SaaS/cloud-based solutions.
- Plan and execute sales and marketing activities to generate qualified opportunities and establish relationships with early adopters and key opinion leaders.
- Support and manage assigned partners throughout onboarding, training, pipeline development, and customer engagement.
- Manage partnership discussions, including sales positioning, target-customer alignment, pricing, commercial terms, and contract negotiations.
- Analyze market trends, competitor activity, customer feedback, and pipeline data to identify opportunities and improve commercial strategy.
- Maintain accurate pipeline and forecasting information through CRM tools and provide market insights to regional and global leadership.
About the company
AIRS Medical develops medical imaging AI and robotics to improve diagnostic workflows. Its flagship product, SwiftMR™, uses deep learning to reconstruct high-quality MRI images from accelerated, lower-quality scans, reducing scan times by up to 50% while maintaining image clarity. The software works as either a cloud-based or on-premise solution and is compatible with all MRI scanner vendors, models, and ages, avoiding costly hardware upgrades. It integrates with existing imaging workflows (DICOM, PACS) and is delivered via subscription or pay-per-use models. AIRS Medical differentiates itself through broad hardware compatibility, validated AI-based reconstruction (including wins at the fastMRI Challenge), and regulatory clearances (FDA 510(k), CE, Japan). Its goal is to shift healthcare from reactive to proactive and preventive care by increasing patient throughput and diagnostic efficiency.
Company Size
51-200
Company Stage
Series C
Total Funding
$41.2M
Headquarters
Seoul, South Korea
Founded
2018
Get referred to AIRS Medical
See people who can refer or advise you
Simplify's Take
What believers are saying
- SimonMed is deploying SwiftMR across 170 centers, a major U.S. reference win.
- July 2026 FDA-cleared Auto Cut MIPs reduces technologist time by five minutes.
- SwiftSight releases in 2026 and 32,000-subject norms support higher-margin expansion.
What critics are saying
- Siemens, Philips, and GE can bundle native reconstruction, squeezing AIRS by 2027.
- SwiftMR still sits inside regulated medical workflows; any FDA recall would stall deployments.
- Revenue depends on hospital purchasing cycles; one lost SimonMed rollout would dent credibility.
What makes AIRS Medical unique
- SwiftMR works across all MRI vendors and ages, avoiding scanner replacement costs.
- SwiftSight adds quantitative MRI and structured reporting, widening AIRS beyond reconstruction alone.
- TA Associates backed AIRS in June 2026, validating global ambition and enterprise scale.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Paid Sick Leave
Paid Holidays
Remote Work Options
Flexible Work Hours
Training Programs
Growth & Insights and Company News
6 month growth
0%1 year growth
0%2 year growth
0%AIRS Medical has received US Food and Drug Administration 510(k) clearance for SwiftSight Body Composition, an AI-powered quantitative MRI solution for body composition analysis. SimonMed Imaging will be the first customer to deploy the technology. The system uses AI to quantify muscle and adipose tissue from MR images in under five minutes, including visceral and subcutaneous fat, abdominal and thigh muscle, muscle quality, and liver fat assessment. Automated analysis produces standardised reports with measurements benchmarked against reference populations. The solution is designed for high-volume imaging centres and enables healthcare organisations to expand MRI services without adding separate equipment. The technology supports repeat assessments over time without ionizing radiation. AIRS Medical plans to expand its quantitative MRI platform with diffusion tensor imaging in November 2026 and joint applications in 2027.
AIRS Medical, a global AI solutions provider for medical imaging, has secured a strategic growth investment from TA Associates to accelerate its international expansion and product development. The investment will support advancement of the company's AI-powered MRI technologies designed to improve imaging efficiency and expand patient access. Founded in 2018, AIRS Medical develops AI-native MRI acceleration and reconstruction software. The company currently supports over 1,700 healthcare institutions across more than 40 countries, with its technologies used in approximately 6 million MRI examinations annually. AIRS Medical's product suite includes SwiftMR, an AI-powered MRI acceleration and image enhancement solution, and SwiftSight, an MRI quantification and structured reporting platform. The company aims to address growing imaging demand and limited capacity challenges facing healthcare providers globally.
Recens Medical, a precision cooling technology company, has set its initial public offering price at KRW 11,000, the top of its indicative range of KRW 9,000-11,000. The bookbuilding attracted 2,261 institutional investors, achieving a subscription rate of 1,352.63 to 1, the highest among Korean IPOs this year. All participating institutions bid at or above the upper range, with 63.9% of orders including lock-up commitments of at least 15 days. The company will raise approximately KRW 15.4 billion through the offering, with an expected market capitalisation of around KRW 119.4 billion. Retail investor subscriptions are scheduled for 19-20 February, with a KOSDAQ listing planned for March. Proceeds will fund manufacturing automation, clinical trials for new indications, and global marketing expansion.
AIRS Medical, a Seoul-based AI and robotics healthcare company, raised $20M in Series C funding led by BSK Investment and Shinyoung Securities. The funds will be used to enhance their product SwiftMR, expand internationally, invest in R&D, and improve patient outcomes. SwiftMR is a deep learning-based solution that reduces MRI scan times by up to 50%.